Skip to main navigation
Skip to search
Skip to main content
Prinses Máxima Centrum Home
Nederlands
English
Search content at Prinses Máxima Centrum
Home
Profiles
Research Groups
Equipment
Research output
Prizes
Activities
Press/Media
Trial Watch: Peptide vaccines in cancer therapy
Fernando Aranda
, Erika Vacchelli
,
Alexander Eggermont
, Jerome Galon
, Catherine Sautès-Fridman
, Eric Tartour
, Laurence Zitvogel
, Guido Kroemer
, Lorenzo Galluzzi
Research output
:
Contribution to journal
›
Review article
›
peer-review
101
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Trial Watch: Peptide vaccines in cancer therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
In Cancer
100%
Cancer Therapy
100%
Anticancer Vaccines
100%
Peptide Vaccine
100%
Anticancer Agents
50%
Tumor
25%
Clinical Trials
25%
Tumor Progression
25%
Immune Response
25%
Tumor Antigen
25%
Malignant Cells
25%
Toll-like
25%
Biological Mechanisms
25%
Cell-based
25%
Oncogenesis
25%
Prophylactic Treatment
25%
Immune System
25%
Receptor Agonist
25%
Adaptive Immune Response
25%
Innate Immune Response
25%
Neoplastic Lesions
25%
Late Development
25%
Immunogenic
25%
Immunological Tolerance
25%
Immune Checkpoint
25%
Clinical Potential
25%
Immunosuppressive Cytokines
25%
Oncoimmunology
25%
High Profile
25%
Antigen-specific Immunity
25%
Component-based
25%
Profile Study
25%
Purified Peptide
25%
Receptor Inhibitors
25%
Antineoplastic
25%
DNA Bases
25%
Immunology and Microbiology
Adaptive Immune System
100%
Peptide Vaccine
100%
Peptides
100%
Agonist
50%
Tumor Antigen
50%
Immune Response
50%
Immune Tolerance
50%
Cytokine
50%
Innate Immune System
50%
Immunosuppressive Drug
50%
Adjuvant
50%
Immune System
50%
Toll-Like Receptor
50%
Pharmacology, Toxicology and Pharmaceutical Science
Toll Like Receptor Antagonist
33%
Medicine and Dentistry
Toll Like Receptor Antagonist
33%